Outcome prediction in large vessel occlusion ischemic stroke with or without endovascular stroke treatment

Autor: Flint, Alexander C, Chan, Shelia L, Edwards, Nancy J, Rao, Vivek A, Klingman, Jeffery G, Nguyen-Huynh, Mai N, Yan, Bernard, Mitchell, Peter J, Davis, Stephen M, Campbell, Bruce Cv, Dippel, Diederik W, Roos, Yvo Bwem, Van Zwam, Wim H, Saver, Jeffrey L, Kidwell, Chelsea S, Hill, Michael D, Goyal, Mayank, Demchuk, Andrew M, Bracard, Serge, Bendszus, Martin, Donnan, Geoffrey A, On Behalf Of The Vista-Endovascular Collaboration
Přispěvatelé: Neurology, Beeldvorming, MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: Carim - B05 Cerebral small vessel disease, RS: Carim - B06 Imaging, ACS - Atherosclerosis & ischemic syndromes, Amsterdam Neuroscience - Neurovascular Disorders
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: International Journal of Stroke, 18(3), 331-337. SAGE Publications Ltd
International journal of stroke, 18(3):17474930221092262, 331-337. SAGE Publications Ltd
International journal of stroke. SAGE Publications Ltd
ISSN: 1747-4949
1747-4930
Popis: Introduction: The THRIVE score and the THRIVE-c calculation are validated ischemic stroke outcome prediction tools based on patient variables that are readily available at initial presentation. Randomized controlled trials (RCTs) have demonstrated the benefit of endovascular treatment (EVT) for many patients with large vessel occlusion (LVO), and pooled data from these trials allow for adaptation of the THRIVE-c calculation for use in shared clinical decision making regarding EVT. Methods: To extend THRIVE-c for use in the context of EVT, we extracted data from the Virtual International Stroke Trials Archive (VISTA) from 7 RCTs of EVT. Models were built in a randomly selected development cohort using logistic regression that included the predictors from THRIVE-c: age, NIH Stroke Scale (NIHSS) score, presence of hypertension, diabetes mellitus, and/or atrial fibrillation, as well as randomization to EVT and, where available, the Alberta Stroke Program Early CT Score (ASPECTS). Results: Good outcome was achieved in 366/787 (46.5%) of subjects randomized to EVT and in 236/795 (29.7%) of subjects randomized to control (P Conclusion: THRIVE-EVT may be used alongside the original THRIVE-c calculation to improve outcome probability estimation for patients with acute ischemic stroke, including patients with or without LVO, and to model the potential improvement in outcomes with EVT for an individual patient based on variables that are available at initial presentation. Online calculators for THRIVE-c estimation are available at www.thrivescore.org and www.mdcalc.com/thrive-score-for-stroke-outcome .
Databáze: OpenAIRE
Externí odkaz: